Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: Mechanisms and therapeutic implications

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 4, 2012, Pages 865-872

  Li, Jun ^a,b   Zhang, Hanrui ^a,b   Zhang, Cuihua ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

Coronary vascular resistance; Inflammatory cells; Microcirculation; Myocardial ischemia; Reperfusion injury

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 6; NITRIC OXIDE; PROSTANOID; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOREGULATION; BLOOD VESSEL TONE; CELL INFILTRATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY VASCULAR RESISTANCE; DISEASE EXACERBATION; HEART MUSCLE ISCHEMIA; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; UPREGULATION; VASOMOTOR REFLEX;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; INFLAMMATION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; VASCULAR RESISTANCE;

EID: 84858287093     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.08.027     Document Type: Review

References (82)

1. Ku D.D. Coronary vascular reactivity after acute myocardial ischemia. Science 1982, 218:576-578.
2. Node K., Kitakaze M., Kosaka H., Komamura K., Minamino T., Tada M., et al. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun 1995, 211:370-374.
3. Smith T.P., Canty J.M. Modulation of coronary autoregulatory responses by nitric oxide. Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 1993, 73:232-240.
4. Zhang H.X., Zang Y.M., Huo J.H., Liang S.J., Zhang H.F., Wang Y.M., et al. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 2006, 48:306-313.
5. Ma H., Zhang H.F., Yu L., Zhang Q.J., Li J., Huo J.H., et al. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res 2006, 69:57-65.
6. Kitakaze M., Node K., Minamino T., Asanuma H., Kuzuya T., Hori M. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Coll Cardiol 1999, 33:242-249.
7. Kitakaze M., Asanuma H., Takashima S., Minamino T., Ueda Y., Sakata Y., et al. Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs. Circulation 2000, 101:311-317.
8. Piana R.N., Wang S.Y., Friedman M., Sellke F.W. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation 1996, 93:544-551.
9. Wang S., Dusting G.J., May C.N., Woodman O.L. 3',4'-Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. Br J Pharmacol 2004, 142:443-452.
10. Ogita H., Node K., Asanuma H., Sanada S., Kim J., Takashima S., et al. Raloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart: role of phosphatidylinositol 3-kinase/Akt pathway. J Cardiovasc Pharmacol 2004, 43:821-829.
11. Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006, 113:1708-1714.
12. Zhang C., Xu X., Potter B.J., Wang W., Kuo L., Michael L., et al. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2006, 26:475-480.
13. Gao X., Xu X., Belmadani S., Park Y., Tang Z., Feldman A.M., et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007, 27:1269-1275.
14. Zhang C., Wu J., Xu X., Potter B.J., Gao X. Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury. Basic Res Cardiol 2010, 105:453-464.
15. Pabla R., Buda A.J., Flynn D.M., Salzberg D.B., Lefer D.J. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 1995, 269:H1113-H1121.
16. Wildhirt S.M., Weismueller S., Schulze C., Conrad N., Kornberg A., Reichart B. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res 1999, 43:698-711.
17. Heinzel F.R., Gres P., Boengler K., Duschin A., Konietzka I., Rassaf T., et al. Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs. Circ Res 2008, 103:1120-1127.
18. Engelman D.T., Watanabe M., Maulik N., Cordis G.A., Engelman R.M., Rousou J.A., et al. L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg 1995, 60:1275-1281.
19. Colagrande L., Formica F., Porta F., Brustia M., Avalli L., Sangalli F., et al. L-arginine effects on myocardial stress in cardiac surgery: preliminary results. Ital Heart J 2005, 6:904-910.
20. Padilla F., Garcia-Dorado D., Agullo L., Inserte J., Paniagua A., Mirabet S., et al. L-arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig. Cardiovasc Res 2000, 46:412-420.
21. Ramzy D., Rao V., Mallidi H., Tumiati L.C., Xu N., Miriuka S., et al. Cardiac allograft preservation using donor-shed blood supplemented with L-arginine. J Heart Lung Transplant 2005, 24:1665-1672.
22. Hobbs A., Foster P., Prescott C., Scotland R., Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation 2004, 110:1231-1235.
23. Lai W.Q., Irwan A.W., Goh H.H., Howe H.S., Yu D.T., Valle-Onate R., et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 2008, 181:8010-8017.
24. Mulders A.C., Mathy M.J. Meyer zu Heringdorf D, ter Braak M, Hajji N, Olthof DC, et al. Activation of sphingosine kinase by muscarinic receptors enhances NO-mediated and attenuates EDHF-mediated vasorelaxation. Basic Res Cardiol 2009, 104:50-59.
25. Shimokawa H., Morikawa K. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol 2005, 39:725-732.
26. Park Y., Capobianco S., Gao X., Falck J.R., Dellsperger K.C., Zhang C. Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008, 295:H1982-H1988.
27. Egashira K., Pipers F.S., Rush J.E., Morgan J.P. Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. J Am Coll Cardiol 1990, 16:1296-1303.
28. Szabo T., Geller L., Merkely B., Selmeci L., Juhasz-Nagy A., Solti F. Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect?. Life Sci 2000, 66:2527-2541.
29. Ramzy D., Rao V., Tumiati L.C., Xu N., Sheshgiri R., Miriuka S., et al. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 2006, 114:I319-I326.
30. Schafer U., Kurz T., Jain D., Hartmann F., Dendorfer A., Tolg R., et al. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation?. Basic Res Cardiol 2002, 97:399-408.
31. Kyriakides Z.S., Kremastinos D.T., Bofilis E., Tousoulis D., Antoniadis A., Webb D.J. Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography. Heart 2000, 84:176-182.
32. Reriani M., Raichlin E., Prasad A., Mathew V., Pumper G.M., Nelson R.E., et al. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 2010, 122:958-966.
33. Taylor A.J., Bobik A., Richards M., Kaye D., Raines G., Gould P., et al. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease. Am Heart J 2004, 148:e10.
34. Mubagwa K., Mullane K., Flameng W. Role of adenosine in the heart and circulation. Cardiovasc Res 1996, 32:797-813.
35. Heusch G. Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve. Basic Res Cardiol 2010, 105:1-5.
36. Koszalka P., Ozuyaman B., Huo Y., Zernecke A., Flogel U., Braun N., et al. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res 2004, 95:814-821.
37. Skyschally A., Schulz R., Gres P., Konietzka I., Martin C., Haude M., et al. Coronary microembolization does not induce acute preconditioning against infarction in pigs-the role of adenosine. Cardiovasc Res 2004, 63:313-322.
38. Kitakaze M., Hori M., Sato H., Takashima S., Inoue M., Kitabatake A., et al. Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 1991, 69:1402-1408.
39. Pitarys C.J., Virmani R., Vildibill H.D., Jackson E.K., Forman M.B. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 1991, 83:237-247.
40. Yang Z., Day Y.J., Toufektsian M.C., Ramos S.I., Marshall M., Wang X.Q., et al. Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 2005, 111:2190-2197.
41. Marzilli M., Orsini E., Marraccini P., Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000, 101:2154-2159.
42. Ross A.M., Gibbons R.J., Stone G.W., Kloner R.A., Alexander R.W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005, 45:1775-1780.
43. Kleinbongard P., Bose D., Baars T., Mohlenkamp S., Konorza T., Schoner S., et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res 2011, 108:344-352.
44. Desmet W., Bogaert J., Dubois C., Sinnaeve P., Adriaenssens T., Pappas C., et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 2011, 32:867-877.
45. Levick S.P., Loch D.C., Taylor S.M., Janicki J.S. Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 2007, 178:641-646.
46. Thiemermann C., Zacharowski K. Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins. Pharmacol. Ther. 2000, 87:61-67.
47. Ehring T., Baumgart D., Krajcar M., Hummelgen M., Kompa S., Heusch G. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation 1994, 90:1368-1385.
48. Schmitz J.M., Apprill P.G., Buja L.M., Willerson J.T., Campbell W.B. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circ Res 1985, 57:223-231.
49. Lamping K.G., Kanatsuka H., Eastham C.L., Chilian W.M., Marcus M.L. Nonuniform vasomotor responses of the coronary microcirculation to serotonin and vasopressin. Circ Res 1989, 65:343-351.
50. Ichikawa Y., Yokoyama M., Akita H., Fukuzaki H. Constriction of a large coronary artery contributes to serotonin-induced myocardial ischemia in the dog with pliable coronary stenosis. J Am Coll Cardiol 1989, 14:449-459. discussion 60-1.
51. Woodman O.L. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs. Br J Pharmacol 1990, 100:153-157.
52. Bekkers S.C., Yazdani S.K., Virmani R., Waltenberger J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol 2010, 55:1649-1660.
53. Prasad A., Stone G.W., Holmes D.R., Gersh B. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion. Circulation 2009, 120:2105-2112.
54. Heusch G., Kleinbongard P., Bose D., Levkau B., Haude M., Schulz R., et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009, 120:1822-1836.
55. Herrmann J., Haude M., Lerman A., Schulz R., Volbracht L., Ge J., et al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001, 103:2339-2345.
56. Bahrmann P., Werner G.S., Heusch G., Ferrari M., Poerner T.C., Voss A., et al. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 2007, 115:600-608.
57. Sezer M., Oflaz H., Goren T., Okcular I., Umman B., Nisanci Y., et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med 2007, 356:1823-1834.
58. Li S., Zhong S., Zeng K., Luo Y., Zhang F., Sun X., et al. Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res Cardiol 2010, 105:139-150.
59. Kloner R.A., Giacomelli F., Alker K.J., Hale S.L., Matthews R., Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991, 84:1758-1772.
60. Ambrosio G., Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 1999, 138:S69-S75.
61. Ritter L.S., McDonagh P.F. Low-flow reperfusion after myocardial ischemia enhances leukocyte accumulation in coronary microcirculation. Am J Physiol 1997, 273:H1154-H1165.
62. Lefer A.M. Role of the beta2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. Ann Thorac Surg 1999, 68:1920-1923.
63. Jones S.P., Trocha S.D., Strange M.B., Granger D.N., Kevil C.G., Bullard D.C., et al. Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2000, 279:H2196-H2201.
64. Sun B., Fan H., Honda T., Fujimaki R., Lafond-Walker A., Masui Y., et al. Activation of NF kappa B and expression of ICAM-1 in ischemic-reperfused canine myocardium. J Mol Cell Cardiol 2001, 33:109-119.
65. Fan H., Sun B., Gu Q., Lafond-Walker A., Cao S., Becker L.C. Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 2002, 282:H1778-H1786.
66. Kukielka G.L., Hawkins H.K., Michael L., Manning A.M., Youker K., Lane C., et al. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 1993, 92:1504-1516.
67. Hawkins H.K., Entman M.L., Zhu J.Y., Youker K.A., Berens K., Dore M., et al. Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody. Am J Pathol 1996, 148:1957-1969.
68. Weyrich A.S., Ma X.Y., Lefer D.J., Albertine K.H., Lefer A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993, 91:2620-2629.
69. Kupatt C., Wichels R., Deiss M., Molnar A., Lebherz C., Raake P., et al. Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs. Gene Ther 2002, 9:518-526.
70. Luo X., Cai H., Ni J., Bhindi R., Lowe H.C., Chesterman C.N., et al. c-Jun DNAzymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 2009, 29:1836-1842.
71. Sakuma T., Sari I., Goodman C.N., Lindner J.R., Klibanov A.L., Kaul S. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty. Cardiovasc Res 2005, 66:552-561.
72. Erlich J.H., Boyle E.M., Labriola J., Kovacich J.C., Santucci R.A., Fearns C., et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 2000, 157:1849-1862.
73. Zahler S., Massoudy P., Hartl H., Hahnel C., Meisner H., Becker B.F. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 1999, 41:722-730.
74. Baldus S., Heitzer T., Eiserich J.P., Lau D., Mollnau H., Ortak M., et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 2004, 37:902-911.
75. Takahashi T., Hiasa Y., Ohara Y., Miyazaki S., Ogura R., Miyajima H., et al. Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. Am J Cardiol 2007, 100:35-40.
76. Tinsley J.H., Wu M.H., Ma W., Taulman A.C., Yuan S.Y. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 1999, 274:24930-24934.
77. Wang M., Zhang W., Crisostomo P., Markel T., Meldrum K.K., Fu X.Y., et al. Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol 2007, 293:H2101-H2108.
78. Bramos D., Ikonomidis I., Tsirikos N., Kottis G., Kostopoulou V., Pamboucas C., et al. The association of coronary flow changes and inflammatory indices to ischaemia-reperfusion microvascular damage and left ventricular remodelling. Basic Res Cardiol 2008, 103:345-355.
79. Becker B.F., Chappell D., Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 2010, 105:687-701.
80. Chappell D., Dorfler N., Jacob M., Rehm M., Welsch U., Conzen P., et al. Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 2010, 34:133-139.
81. Chappell D., Hofmann-Kiefer K., Jacob M., Rehm M., Briegel J., Welsch U., et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009, 104:78-89.
82. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906.